Translation of "Novel therapy" in German

Cell morphology would be a novel approach for therapy,” says Remy.

The novel therapy and the pancreas system may eliminate the need for immunosuppressive drugs to prevent graft rejection.

Horse Allo 20 was developed as a novel therapy medicine containing cells that have been manipulated so that they can be used to repair, regenerate or replace tissue.

Today, a two-day conference on stem cell research came to the conclusion that more research is needed before anyone can predict with confidence the future outcome of this kind of novel therapy.

Even though research extends over the entire spectrum of possible therapeutic approaches, nevertheless only a very few substances promise the prospect of a novel successful therapy.

The invention relates to novel 1-aryloxypropanolamines, their preparation and the use of the novel compounds in therapy, particularly the treatment or prophylaxis of hypertension.

This problem has to be solved to comply with the requirements for saftey of this novel form of therapy and to be able to use herpes virus gene vectors in gene therapy in humans.

Thus, the novel gene therapy system may be introduced both via conventional viral or non-viral vectors and also via a retrovirus vector into the organism in which it has a substantially more selective effect on the tumour than has previously been possible.

Based on these trains of thought, a novel cancer therapy has been developed whose effectiveness has been confirmed in animal experiments and which has already proved clinically successful in individual cases.

This novel cancer therapy consists in a method of selectively dissolving cancer cells in live organisms of warm-blooded species by administering in combination, namely either one shortly after the other or in the form of a mixture, by way of injection or infusion, a protein fraction with oxygen activity from the photosynthetic system of plants or precursors thereof and a protein mixture of embryonic tissue or maternal uterus tissue of placentals, administration being carried out in the form of sterile, isotonic and endotoxin-free solutions.

The patent claims of the present application are intended to cover the aspects, accessible to patent law, of the novel cancer therapy which is disclosed with the present application and which represents a solution for the task of providing therapy which makes possible selective dissolution of cancer cells using medicaments which are entirely harmless for the healthy body and healthy cells.

In what follows, the novel cancer therapy according to the invention will be explained in greater detail by the detailed description of the preparation of the materials used, the results of the animal experiments, and the clinical findings.

For Hamburg cancer patients with a Turkish background a novel "therapy without borders" is available in the newly founded intercultural network for cancer therapy.

Goals include the application and development of new imaging processes and contract agents for the system-biological explanation of pathophysical relationships and for evaluating novel therapy concepts.

Zelboraf, our novel, personalised therapy for metastatic melanoma, the most aggressive form of skin cancer, is a major milestone for patients and their doctors, and for Roche.

Thus, the novel gene therapy system may be introduced both via conventional viral or non-viral vectors and also via a retrovirus vector into the organism in which it has a substantially more selective effect on the tumor than has previously been possible.

Given this background, it is the object of the present invention to provide a novel therapy approach being complementary to the previous therapy approaches oriented toward cytotoxicity, by means of which the development, the formation, and the growth of tumors can efficiently be treated or even prevented.

For patients who, for the cited substance classes, are either therapy resistant or were already suffering from their side effects or who have rejected the therapy using the substance groups, this represents a completely novel therapy approach.

The compounds of the present invention offer a novel potential therapy for the treatment of hypertension, pulmonary hypertension, myocardial infarct, angina pectoris, acute kidney failure, renal insufficiency, cerebral vasospasms, cerebral ischemia, subarachnoid hemorrhages, migraine, asthma, atherosclerosis, endotoxic shock, endotoxin-induced organ failure, intravascular coagulation, restenosis after angioplasty, benign prostate hyperplasia, kidney failure caused by ischemia and by intoxication, and hypertension, and of cancers, in particular prostate cancer and skin cancer.

It is furthermore known that blocking antibodies, as are to be used in the novel therapy, occur in many patients suffering from Graves' disease without the occurrence of such blocking antibodies being correlated with any effects which are adverse to health.

The availability of such selective blocking antibodies against the TSH receptor makes it possible to consider a novel therapy of Graves' disease, which is characterized by the use of such blocking antibodies or the use of such antibodies for the preparation of drugs and the administration of such drugs, usually by injection or infusion.

The novel therapy principle of the present invention, which has not heretofore been described in the art, is not obvious at all in terms of immunology.

Medication-assisted boosting of the parasympathetic nervous system by a direct effect on M2R could constitute a novel therapy option.